I reached out to a good friend of mine who is an investment...

I reached out to a good friend of mine who is an investment banker, and I asked him for a rough valutation for EYE (as a favour to me) - known him since school. He spent about 30-40mins looking at the data, but he is experienced so that is reasonable. The full analysis would take longer, so this is taking into account high level assumptions.

They calculated the share price to fall within a range of 0.510 to 0.970. So he would have used financial ratios, the price-to-sales (P/S) ratio, applied to the company's annualized revenue run rate etc.. I'm guessing by referencing comparable companies in the medical technology sector and factoring in current market conditions as well.

Again, this was whipped up fast, but this person is very skilled at equity valuation. Of course take it with a grain of salt as it is purely based on data and sentiment is a weird thing.